1887

Journal of Medical Microbiology logo

Volume 72, Issue 6

encoding Shiga toxin subtype Stx2f causing human infections in England, 2015–2022 Open Access

Abstract

Shiga toxin-producing (STEC) belong to a diverse group of gastrointestinal pathogens defined by the presence of Shiga toxin genes () of which there are at least ten subtypes (Stx1a-Stx1d and Stx2a-Stx2g).

Initially thought to be associated with mild symptoms, more recently STEC encoding have been isolated from cases of haemolytic uraemic syndrome (HUS) and the clinical significance and public health burden require further investigation.

We analysed clinical outcomes and genome-sequencing data linked to patients infected with STEC encoding- in England to assess the risk to public health.

One hundred and twelve (=58 isolates encoded ; =54 isolates belonging to CC122 or CC722 that had but were negative for ) isolated from patients' faecal specimens between 2015 and 2022 were genome sequenced and linked to epidemiological and clinical outcome data. All isolates were investigated for the presence of virulence genes and a maximum-likelihood phylogeny of isolates belonging to CC122 and CC722 was constructed.

There were 52 cases infected with STEC harbouring between 2015 and 2022, with the majority identified in 2022. Most cases resided in the North of England (=39/52, 75 %), were female (=31, 59.6 %) and/or aged five and under (=29, 55.8 %). Clinical outcome data were available for 40/52 cases (76.9 %) and 7/40(17.5 %) were diagnosed with STEC-HUS. In the two most common clonal complexes, CC122 and CC722, the presence of the -encoding prophage correlated with the presence of additional virulence genes, and , located on an 85kbp IncFIB plasmid.

Certain serotypes of harbouring cause severe clinical outcomes, including STEC-HUS. Public health advice and possible interventions are limited, as little is known about the animal and environmental reservoirs and transmission routes. We recommend more comprehensive and standardized collection of microbiological and epidemiological data, and routine sharing of sequencing data between public health agencies worldwide.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): haemolytic uraemic syndrome , public health surveillance , Shiga toxin subtype and Shiga toxin-producing Escherichia coli
Funding
This study was supported by the:
  • National Institute for Health Research Health Protection Research Unit (Award 111815)
    • Principle Award Recipient: clairejenkins
© 2023 Crown Copyright
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001707
2023-06-09
2024-05-02
Loading full text...

Full text loading...

/deliver/fulltext/jmm/72/6/jmm001707.html?itemId=/content/journal/jmm/10.1099/jmm.0.001707&mimeType=html&fmt=ahah

References

  1. Scotland SM, Smith HR, Rowe B. Two distinct toxins active on Vero cells from Escherichia coli O157. Lancet 1985; 2:885–886 [View Article] [PubMed]
     [Google Scholar]
  2. Persson S, Olsen KEP, Ethelberg S, Scheutz F. Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations. J Clin Microbiol 2007; 45:2020–2024 [View Article] [PubMed]
     [Google Scholar]
  3. Scheutz F, Teel LD, Beutin L, Piérard D, Buvens G et al. Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature. J Clin Microbiol 2012; 50:2951–2963 [View Article] [PubMed]
     [Google Scholar]
  4. Vishram B, Jenkins C, Greig DR, Godbole G, Carroll K et al. The emerging importance of Shiga toxin-producing Escherichia coli other than serogroup O157 in England. J Med Microbiol 2021; 70: [View Article]
     [Google Scholar]
  5. Karch H, Mellmann A, Bielaszewska M. Epidemiology and pathogenesis of enterohaemorrhagic Escherichia coil. Berl Munch Tierarztl Wochenschr 2009; 122:417–424 [PubMed]
     [Google Scholar]
  6. Persad AK, LeJeune JT. Animal reservoirs of Shiga toxin-producing Escherichia coli. Microbiol Spectr 2014; 2:EHEC–0027 [View Article] [PubMed]
     [Google Scholar]
  7. Espinosa L, Gray A, Duffy G, Fanning S, McMahon BJ. A scoping review on the prevalence of Shiga-toxigenic Escherichia coli in wild animal species. Zoonoses Public Health 2018; 65:911–920 [View Article] [PubMed]
     [Google Scholar]
  8. Caprioli A, Scavia G, Morabito S. Public health microbiology of Shiga toxin-producing Escherichia coli. Microbiol Spectr 2014; 2: [View Article] [PubMed]
     [Google Scholar]
  9. Adams NL, Byrne L, Smith GA, Elson R, Harris JP et al. Shiga Toxin-producing Escherichia coli O157, England and Wales, 1983-2012. Emerg Infect Dis 2016; 22:590–597 [View Article] [PubMed]
     [Google Scholar]
  10. Jenkins C, Byrne L, Vishram B, Sawyer C, Balasegaram S et al. Shiga toxin-producing Escherichia coli haemolytic uraemic syndrome (STEC-HUS): diagnosis, surveillance and public-health management in England. J Med Microbiol 2020; 69:1034–1036 [View Article] [PubMed]
     [Google Scholar]
  11. Tong P, Zhang L, Xie J, Zhang M, Tang X et al. Molecular characteristics and virulence gene analysis of non-O157 Shiga toxin–producing Escherichia coli from cattle in Xinjiang. Foodborne Pathog Dis 2021; 18:867–872 [View Article]
     [Google Scholar]
  12. Capps KM, Ludwig JB, Shridhar PB, Shi X, Roberts E et al. Identification, Shiga toxin subtypes and prevalence of minor serogroups of Shiga toxin-producing Escherichia coli in feedlot cattle feces. Sci Rep 2021; 11:8601 [View Article] [PubMed]
     [Google Scholar]
  13. Liu Y, Li H, Chen X, Tong P, Zhang Y et al. Characterization of Shiga toxin‐producing Escherichia coli isolated from Cattle and Sheep in Xinjiang province, China, using whole‐genome sequencing. Transbounding Emerging Dis 2022; 69:413–422 [View Article]
     [Google Scholar]
  14. McCarthy SC, Macori G, Duggan G, Burgess CM, Fanning S et al. Prevalence and whole-genome sequence-based analysis of Shiga toxin-producing Escherichia coli isolates from the recto-anal junction of slaughter-age irish sheep. Appl Environ Microbiol 2021; 87:e0138421 [View Article] [PubMed]
     [Google Scholar]
  15. Brett KN, Ramachandran V, Hornitzky MA, Bettelheim KA, Walker MJ et al. stx1c Is the most common Shiga toxin 1 subtype among Shiga toxin-producing Escherichia coli isolates from sheep but not among isolates from cattle. J Clin Microbiol 2003; 41:926–936 [View Article] [PubMed]
     [Google Scholar]
  16. Martin A, Beutin L. Characteristics of Shiga toxin-producing Escherichia coli from meat and milk products of different origins and association with food producing animals as main contamination sources. Int J Food Microbiol 2011; 146:99–104 [View Article] [PubMed]
     [Google Scholar]
  17. Casanova NA, Redondo LM, Dailoff GC, Arenas D, Fernández Miyakawa ME. Overview of the role of Shiga toxins in porcine edema disease pathogenesis. Toxicon 2018; 148:149–154 [View Article] [PubMed]
     [Google Scholar]
  18. Leung PHM, Peiris JSM, Ng WWS, Robins-Browne RM, Bettelheim KA et al. A newly discovered verotoxin variant, VT2g, produced by bovine verocytotoxigenic Escherichia coli. Appl Environ Microbiol 2003; 69:7549–7553 [View Article] [PubMed]
     [Google Scholar]
  19. Schmidt H, Scheef J, Morabito S, Caprioli A, Wieler LH et al. A new Shiga toxin 2 variant (Stx2f) from Escherichia coli isolated from pigeons. Appl Environ Microbiol 2000; 66:1205–1208 [View Article] [PubMed]
     [Google Scholar]
  20. Morabito S, Dell’Omo G, Agrimi U, Schmidt H, Karch H et al. Detection and characterization of Shiga toxin-producing Escherichia coli in feral pigeons. Vet Microbiol 2001; 82:275–283 [View Article] [PubMed]
     [Google Scholar]
  21. Farooq S, Hussain I, Mir MA, Bhat MA, Wani SA. Isolation of atypical enteropathogenic Escherichia coli and Shiga toxin 1 and 2f-producing Escherichia coli from avian species in India. Lett Appl Microbiol 2009; 48:692–697 [View Article] [PubMed]
     [Google Scholar]
  22. Askari Badouei M, Zahraei Salehi T, Koochakzadeh A, Kalantari A, Tabatabaei S. Molecular characterization, genetic diversity and antibacterial susceptibility of Escherichia coli encoding Shiga toxin 2f in domestic pigeons. Lett Appl Microbiol 2014; 59:370–376 [View Article] [PubMed]
     [Google Scholar]
  23. Friedrich AW, Bielaszewska M, Zhang W-L, Pulz M, Kuczius T et al. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 2002; 185:74–84 [View Article] [PubMed]
     [Google Scholar]
  24. Prager R, Fruth A, Siewert U, Strutz U, Tschäpe H. Escherichia coli encoding Shiga toxin 2f as an emerging human pathogen. Int J Med Microbiol 2009; 299:343–353 [View Article] [PubMed]
     [Google Scholar]
  25. Friesema I, van der Zwaluw K, Schuurman T, Kooistra-Smid M, Franz E et al. Emergence of Escherichia coli encoding Shiga toxin 2f in human Shiga toxin-producing E. coli (STEC) infections in the Netherlands, January 2008 to December 2011. Euro Surveill 2014; 19:26–32 [PubMed]
     [Google Scholar]
  26. Friesema IHM, Keijzer-Veen MG, Koppejan M, Schipper HS, van Griethuysen AJ et al. Hemolytic uremic syndrome associated with Escherichia coli O8:H19 and Shiga toxin 2f gene. Emerg Infect Dis 2015; 21:168–169 [View Article] [PubMed]
     [Google Scholar]
  27. Grande L, Michelacci V, Bondì R, Gigliucci F, Franz E et al. Whole-genome characterization and strain comparison of VT2f-producing Escherichia coli causing hemolytic uremic syndrome. Emerg Infect Dis 2016; 22:2078–2086 [View Article] [PubMed]
     [Google Scholar]
  28. De Rauw K, Jacobs S, Piérard D. Twenty-seven years of screening for Shiga toxin-producing Escherichia coli in a university hospital. Brussels, Belgium, 1987-2014. PLoS One 2018; 13:e0199968 [View Article] [PubMed]
     [Google Scholar]
  29. Cointe A, Birgy A, Pascault A, Louillet F, Dufougeray A et al. Be aware of Shiga-toxin 2f-producing Escherichia coli: case report and false-negative results with certain rapid molecular panels. Diagn Microbiol Infect Dis 2020; 98:115177 [View Article] [PubMed]
     [Google Scholar]
  30. Skinner C, McMahon S, Rasooly R, Carter JM, He X. Purification and characterization of Shiga toxin 2f, an immunologically unrelated subtype of Shiga toxin 2. PLoS One 2013; 8:e59760 [View Article] [PubMed]
     [Google Scholar]
  31. De Rauw K, Detemmerman L, Breynaert J, Piérard D. Detection of Shiga toxin-producing and other diarrheagenic Escherichia coli by the biofire filmarray gastrointestinal panel in human fecal samples. Eur J Clin Microbiol Infect Dis 2016; 35:1479–1486 [View Article] [PubMed]
     [Google Scholar]
  32. Staples M, Fang NX, Graham RM, Smith HV, Jennison AV. Evaluation of the SHIGA TOXIN QUIK CHEK and ImmunoCard STAT! EHEC as screening tools for the detection of SHIGA TOXIN in fecal specimens. Diagn Microbiol Infect Dis 2017; 87:95–99 [View Article] [PubMed]
     [Google Scholar]
  33. Nakamura K, Tokuda C, Arimitsu H, Etoh Y, Hamasaki M et al. Development of a homogeneous time-resolved FRET (HTRF) assay for the quantification of Shiga toxin 2 produced by E. coli. PeerJ 2021; 9:e11871 [View Article] [PubMed]
     [Google Scholar]
  34. Berenger BM, Chui L, Ferrato C, Lloyd T, Li V et al. Performance of four commercial real-time PCR assays for the detection of bacterial enteric pathogens in clinical samples. Int J Infect Dis 2022; 114:195–201 [View Article] [PubMed]
     [Google Scholar]
  35. Jenkins C, Perry NT, Godbole G, Gharbia S. Evaluation of chromogenic selective agar (CHROMagar STEC) for the direct detection of Shiga toxin-producing Escherichia coli from faecal specimens. J Med Microbiol 2020; 69:487–491 [View Article] [PubMed]
     [Google Scholar]
  36. Chattaway MA, Dallman TJ, Gentle A, Wright MJ, Long SE et al. Whole genome sequencing for Public Health Surveillance of Shiga toxin-producing Escherichia coli other than serogroup O157. Front Microbiol 2016; 7:258 [View Article]
     [Google Scholar]
  37. Tewolde R, Dallman T, Schaefer U, Sheppard CL, Ashton P et al. MOST: a modified MLST typing tool based on short read sequencing. PeerJ 2016; 4:e2308 [View Article]
     [Google Scholar]
  38. van Hoek AHAM, van Veldhuizen JNJ, Friesema I, Coipan C, Rossen JWA et al. Comparative genomics reveals a lack of evidence for pigeons as a main source of stx2f-carrying Escherichia coli causing disease in humans and the common existence of hybrid Shiga toxin-producing and enteropathogenic E. coli pathotypes. BMC Genomics 2019; 20:271 [View Article] [PubMed]
     [Google Scholar]
  39. Dallman T, Ashton P, Schafer U, Jironkin A, Painset A et al. SnapperDB: a database solution for routine sequencing analysis of bacterial isolates. Bioinformatics 2018; 34:3028–3029 [View Article] [PubMed]
     [Google Scholar]
  40. Zhou Z, Alikhan NF, Mohamed K, Fan Y, Achtman M. The enterobase user’s guide, with case studies on Salmonella transmissions, Yersinia pestis phylogeny, and Escherichia core genomic diversity. Genome Res 2020; 30:40 [View Article]
     [Google Scholar]
  41. Prjibelski A, Antipov D, Meleshko D, Lapidus A, Korobeynikov A. Using SPAdes De Novo assembler. Curr Protoc Bioinformatics 2020; 70:e102 [View Article] [PubMed]
     [Google Scholar]
  42. Vishram B, Jenkins C, Greig DR, Godbole G, Carroll K et al. The emerging importance of Shiga toxin-producing Escherichia coli other than serogroup O157 in England. J Med Microbiol 2021; 70:001375 [View Article] [PubMed]
     [Google Scholar]
  43. Rodwell EV, Vishram B, Smith R, Browning L, Smith-Palmer A et al. Epidemiology and genomic analysis of Shiga toxin-producing Escherichia coli clonal complex 165 in the UK. J Med Microbiol 2021; 70:12 [View Article] [PubMed]
     [Google Scholar]
  44. Rodwell EV, Chan Y-W, Sawyer C, Carroll A, McNamara E et al. Shiga toxin-producing Escherichia coli clonal complex 32, including serotype O145:H28, in the UK and Ireland. J Med Microbiol 2022; 71: [View Article] [PubMed]
     [Google Scholar]
  45. Rodwell EV, Simpson A, Chan YW, Godbole G, McCarthy ND et al. The epidemiology of Shiga toxin-producing Escherichia coli O26:H11 (clonal complex 29) in England, 2014-2021. J Infect 2023S0163-4453(23)00206-2 [View Article] [PubMed]
     [Google Scholar]
  46. Butt S, Jenkins C, Godbole G, Byrne L. The epidemiology of Shiga toxin-producing Escherichia coli serogroup O157 in England, 2009-2019. Epidemiol Infect 2022; 150:e52 [View Article] [PubMed]
     [Google Scholar]
  47. Kim TY, La TM, Kim T, Yun SA, Lee SW et al. Whole-genome sequencing analysis of a stx-negative Escherichia coli O63:H6 isolate associated with hemolytic uremic syndrome. Diagnostics 2021; 11:1823 [View Article]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001707
Loading
Escherichia coli encoding Shiga toxin subtype Stx2f causing human infections in England, 2015–2022
J. Med. Microbiol. 72, 001707 (2023); https://doi.org/10.1099/jmm.0.001707
/content/journal/jmm/10.1099/jmm.0.001707
/content/journal/jmm/10.1099/jmm.0.001707
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error